← Back to Search

Spinal Implant

PCSS Surgery for Degenerative Disc Disease (FUSE Trial)

N/A
Waitlist Available
Research Sponsored by Providence Medical Technology, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Indicated for ACDF treatment of degenerative disc disease (DDD) between and including C3-C7 at 3 contiguous levels
Reported to be medically cleared for surgery
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 24 months
Awards & highlights

FUSE Trial Summary

This trial will study a new device to see if it's safe and effective in treating cervical degenerative disease.

Who is the study for?
Adults aged 18-80 with multi-level cervical degenerative disc disease unresponsive to non-surgical treatments, indicated for ACDF between C3-C7. Must be able to follow the study protocol and attend follow-ups. Excludes those with severe obesity, infections, certain previous spine conditions or surgeries, substance abuse issues, mental illness affecting consent or compliance, pregnancy plans within three years, recent investigational drug/device use.Check my eligibility
What is being tested?
The trial is testing a device called PCSS alongside posterior cervical fusion and anterior cervical discectomy and fusion in treating multi-level degenerative disc disease of the neck. The goal is to assess safety and effectiveness of this combined surgical approach.See study design
What are the potential side effects?
Potential side effects may include typical risks associated with spinal surgery such as pain at the site of surgery, infection risk, nerve damage that could lead to weakness or numbness, bleeding complications or reactions to anesthesia.

FUSE Trial Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I need surgery for disc disease in my neck between C3 and C7.
Select...
My doctor has approved me for surgery.
Select...
I am between 18 and 80 years old.
Select...
I am able and willing to follow the study's requirements and attend all scheduled visits.
Select...
My condition did not improve with basic treatments like rest, heat, or painkillers.

FUSE Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~24 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 24 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Superiority in Fusion Success in CCF (treatment) compared to ACDF (control)
Secondary outcome measures
Non-inferiority Composite Safety Success in CCF (treatment) compared to ACDF (control)

FUSE Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Circumferential Cervical Fusion (CCF)Experimental Treatment1 Intervention
Circumferential Cervical Fusion (CCF) is a combination of ACDF and Posterior Cervical Fusion (PCF) procedures. The PCF is completed with Posterior Cervical Stabilization System (PCSS).
Group II: Anterior Cervical Discectomy and Fusion (ACDF)Active Control1 Intervention
ACDF is a a standard of care procedure that is performed using standard instruments and completed with an allograft interbody implant and anterior plate. The plate is intended to stabilize the treated levels until fusion occurs.

Find a Location

Who is running the clinical trial?

Providence Medical Technology, Inc.Lead Sponsor
2 Previous Clinical Trials
Victoria SumnersStudy DirectorProvidence Medical Technology, Inc.
Matt JenkinsStudy DirectorProvidence Medical Technology, Inc.

Media Library

Posterior Cervical Stabilization System (PCSS) (Spinal Implant) Clinical Trial Eligibility Overview. Trial Name: NCT04229017 — N/A
Degenerative Disc Disease Research Study Groups: Anterior Cervical Discectomy and Fusion (ACDF), Circumferential Cervical Fusion (CCF)
Degenerative Disc Disease Clinical Trial 2023: Posterior Cervical Stabilization System (PCSS) Highlights & Side Effects. Trial Name: NCT04229017 — N/A
Posterior Cervical Stabilization System (PCSS) (Spinal Implant) 2023 Treatment Timeline for Medical Study. Trial Name: NCT04229017 — N/A
Degenerative Disc Disease Patient Testimony for trial: Trial Name: NCT04229017 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Who are the ideal candidates for participating in this research?

"This trial seeks 330 participants between the age of 18 and 80 who have intervertebral disc degeneration. To qualify, applicants must demonstrate a Neck Disability Index (NDI) score of at least 15/50, be unresponsive to non-operative conservative treatments such as physical therapy or pain relievers, comprehend required forms and documents in addition to being willing and able to attend follow-up visits."

Answered by AI

Is enrollment currently available for this clinical experiment?

"Affirmative. According to information available on clinicaltrials.gov, this medical trial is currently seeking participants. The study was initially posted on March 18th 2020 and the most recent update occurred September 26th 2022; 330 patients are needed across 17 different sites."

Answered by AI

How pervasive is this research taking place across the city?

"Patients can enrol in this study at 17 different medical facilities, such as Atlantic Neurosurgical & Spine Specialists in Wilmington and Barrow Neurological Institute in Phoenix. Additionally, OrthoNorCal offers the trial to patients located within Los Gatos."

Answered by AI

Do people who are 40 years or older qualify for participation in this clinical experiment?

"This study is open to those aged 18 - 80 who meet the prerequisites for entry."

Answered by AI

How many individuals have been enrolled in this clinical research project?

"This clinical trial necessitates 330 participants that meet the established eligibility requirements. Providence Medical Technology, Inc., is overseeing this initiative and will be utilizing medical centres such as Atlantic Neurosurgical & Spine Specialists in Wilmington and Barrow Neurological Institute in Phoenix for recruitment."

Answered by AI

Who else is applying?

What state do they live in?
California
Oklahoma
North Carolina
How old are they?
65+
18 - 65
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
What site did they apply to?
OrthoNorCal
Atlantic Neurosurgical & Spine Specialists
Baylor College of Medicine
How many prior treatments have patients received?
3+

Why did patients apply to this trial?

Physical therapy and opioids, Celebrex are not helping. Pain is not letting me sleep.
PatientReceived 2+ prior treatments
I’ve had chronic back pain from degenerative discs for decades. PT, chiropractic, stem cell therapy, RF ablation and meds haven’t offered sustained relief.
PatientReceived no prior treatments
~49 spots leftby Jun 2025